Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
61 (5%)
Anticipated shortage:
0 (0%)
Avoided shortage:
36 (3%)
Resolved:
1223 (93%)
1320
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
283 (99%)
Reversed:
2 (1%)
287
211 (13%)
35 (56%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
| PMS-BUPRENORPHINE-NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2024-07-24 | 2024-10-09 | 233605 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-19 | 8925 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-08-11 | 2018-05-05 | 18860 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2017-09-19 | 2018-04-19 | 22744 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2017-10-12 | 2018-04-19 | 25743 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2017-10-12 | 2018-02-17 | 25746 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2019-11-15 | 2020-05-19 | 98802 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2021-07-29 | 2021-08-30 | 143172 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2023-04-14 | 2023-08-17 | 189598 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-15 | 2024-07-10 | 222369 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149400 |
| PMS-ERLOTINIB | 150MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149371 |
| PMS-ERLOTINIB | 100MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149368 |
| PMS-ESOMEPRAZOLE DR | 40MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-15 | 2021-10-27 | 117909 |
| PMS-FAMCICLOVIR | 125MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149412 |
| PMS-FAMCICLOVIR | 125MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117852 |
| PMS-FAMCICLOVIR | 250MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117855 |
| PMS-FAMCICLOVIR | 500MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117858 |
| PMS-FENTANYL MTX | 12MCG | PATCH | Discontinued | 2022-07-25 | 2022-11-25 | 165462 |
| PMS-FENTANYL MTX | 75MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158296 |
| PMS-FENTANYL MTX | 50MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158299 |
| PMS-FENTANYL MTX | 100MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158293 |
| PMS-FENTANYL MTX | 25MCG | PATCH | Discontinued | 2022-04-07 | 2022-04-07 | 158304 |
| PMS-FENTANYL MTX | 12MCG | PATCH | Discontinued | 2022-07-25 | 2022-11-25 | 165397 |
| PMS-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6051 |
| PMS-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-10-12 | 2017-10-12 | 25717 |
| PMS-GABAPENTIN | 600MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117796 |
| PMS-GABAPENTIN | 800MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117801 |
| PMS-GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147352 |
| PMS-GALANTAMINE ER | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-10-15 | 2021-10-15 | 147347 |